Ovarian reserve in antiphospholipid syndrome: the jury is still out

Abstract

Get full access to this article

View all access options for this article.

References

Yamakami

YLYS

Serafini

de Araujo

. Ovarian reserve in women with primary antiphospholipid syndrome. Lupus 2014; 23: 862–867.

Deweilly

Andersen

Balen

. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014; 20: 370–385.

Leader

Baker

. Maximizing the clinical utility of antimüllerian hormone testing in women’s health. Curr Opin Obstet Gynecol 2014; 26: 226–236.

Clark

Laskin

Cadesky

. Anti-Müllerian hormone: Reality check. Hum Reprod 2014; 29: 184–185.

Gleicher

Weghofer

Barad

. Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril 2010; 94: 2824–2827.